[Academic Paper Published] The results of our collaborative research on VHH antibody powdering have been published in the journal Antibodies.
Epsilon Molecular Engineering Co., Ltd. (Head office: Saitama City, Saitama Prefecture; Representative Director: Naoto Nemoto; hereinafter referred to as "the Company") is pleased to announce the publication of "A Novel Method for Preparing Uniform Micro-Sized Dry Powder Formulations, Including Aggregation-Controlled VHH" in the journal Antibodies, as a result of joint research with Ricoh Co., Ltd. (Head office: Ota Ward, Tokyo; Representative Director: Akira Oyama; hereinafter referred to as "Ricoh") on VHH antibody powder formulation.
The article isCLICK HERE.
This research paper evaluates Ricoh's proprietary Fine Droplet Drying (FDD)* technology for antibody powdering, focusing on our PharmaLogical® VHH antibody, which boasts excellent thermal stability and reconstitution properties. The VHH antibody was observed as uniform microparticles after FDD, and the results showed good inhalation characteristics. Furthermore, it was confirmed that the remaining powdered VHH antibody remained stable for more than two years at room temperature, suggesting that the FDD method for powdering VHH antibodies has potential applications in pharmaceuticals in the future.
Our company offers a high-throughput screening platform for humanized VHH antibodies that combines our proprietary VHH library, PharmaLogical® Library, with the cDNA display method.The MonthWe have established a [specific technology/system] and are using it for joint research with domestic and international companies, among other business development activities.
If you are interested in or have any questions about our technology,CLICK HERE us through our inquiry form.
* "Fine Droplet Drying" and "FDD" are registered trademarks of Ricoh Co., Ltd.